Manufacturing

Review of SUT Adoption in Biopharma Manufacturing

The evolution of therapeutic modalities drives the adoption of single-use technologies.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Automating the Future of Fill/Finish

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

Navigating Biopharma Complexity: Why Long-Term Partnerships Matter

February 25, 2026

Trust-based CDMO partnerships are becoming essential to accelerate injectable drug development, manage risk, and ensure resilient biopharma supply.

Reasons to Pay Attention to Makary's Comments Around Losing Drug Development Ground to China

February 20, 2026

FDA commissioner warns US trial startup delays may cede early drug development to China, urging IND and IRB process reforms amid global competitions.

Johnson & Johnson Announces $1B Investment in Pennsylvania Manufacturing Site

February 19, 2026

A $1 Billion Pennsylvania cell therapy site investment bolsters domestic manufacturing, creating 500 skilled biomanufacturing jobs.

Women Making an Impact

February 11, 2026

PharmTech spoke with women working in the pharmaceutical industry about the innovations they are seeing in bio/pharma and the role women play in the development of critical treatments for patients.

Fresenius Kabi and Phlow Corp. Enter First US End-to-End Manufacturing Collaboration

February 09, 2026

Fresenius Kabi and Phlow partner to onshore US epinephrine production, securing the domestic supply chain for essential medicines.

How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs

February 06, 2026

Integrated CDMO networks streamline complex drug development across advanced modalities like ADCs.

Women in STEM: Cultivating Scientific Confidence

February 04, 2026

PharmTech spoke with Elisabeth Gardiner, chief scientific officer at Tevard Biosciences, about how hands-on, early exposure to STEM fields can demystify complex concepts.

Webcasts